Iomedico Ag

This study watches how well ropeginterferon alfa-2b works for adults with polycythemia vera who do not have an enlarged spleen. Researchers will track symptoms, blood counts, and side effects over 36 months. About 200 people will join to see if the drug helps control the disease …

This study looks at how well the drug ivosidenib works for people with advanced bile duct cancer that has a specific IDH1 gene mutation. About 100 adults in Germany who have already tried at least one other cancer treatment will take part. Researchers will track how long the canc…

This study tracks 150 adults in Germany with metastatic colorectal cancer who are taking Fruquintinib after other treatments stopped working. Researchers will see how well the drug controls the cancer in real-life settings, including survival, side effects, and quality of life. T…

This study follows about 150 adults with a specific type of slow-growing brain tumor (IDH-mutant grade 2 glioma) who are taking the drug vorasidenib after surgery. The main goal is to see how the treatment affects their quality of life, including symptoms like seizures. Researche…

This study is a large registry that will follow 2200 people with multiple myeloma in Germany. Its goal is to collect information on the types of treatments patients actually receive, how well they work, and how patients feel over time. Participants will provide medical data and o…

This study follows about 705 adults with Waldenström's macroglobulinemia, chronic lymphocytic leukemia, marginal zone lymphoma, or follicular lymphoma who are already taking or starting zanubrutinib. Researchers will track hospital visits, emergency room use, and quality of life …

This study is not testing a new treatment. Instead, it will follow about 200 people in Germany who have myelofibrosis (a bone marrow disorder) and anemia (low red blood cells). Researchers will record which treatments doctors choose, how the disease changes, and how patients feel…

This study is a registry that collects information from about 1,975 people with advanced ovarian or endometrial cancer in Germany. Researchers will track treatments, test results, and how patients feel over time. The goal is to understand real-world care and outcomes, not to test…

This study is a large registry that follows about 1,930 people with advanced kidney or bladder cancer in Germany. Researchers will collect information on treatments, disease progression, quality of life, and tumor samples to understand how these cancers are managed in everyday pr…

This study is a large registry that will collect information from about 1,900 people with advanced cancer of the esophagus or stomach who are receiving palliative treatment in Germany. The goal is to understand what treatments are actually used in everyday practice and how patien…

This study is a large registry that will collect information from about 2,950 adults with certain blood cancers (like CLL and lymphomas) in Germany. Researchers will track what treatments people receive, how their disease responds, and how their quality of life changes over time.…